文献速递糖尿病肥胖与代谢综合征

限时进食与个体化营养指导对2型糖尿病风险成人血糖结局的非劣效随机临床试验

Time-restricted eating versus dietetic guidance on glycaemic outcomes in adults at risk of type 2 diabetes: a non-inferiority randomised clinical trial.
PubMed 文献 · Diabetologia · 2026-06-06

4个月时限时进食对HbA1c的改善非劣效于营养指导,但12个月时非劣效性无法确定;两组绝对变化均较小且无临床意义。

要点

  • 4个月时限时进食对HbA1c改善非劣效于个体化营养指导,但未显示优效。
  • 12个月时组间差异上界超过非劣效界值,非劣效性无法确定。
  • 两组HbA1c绝对变化均较小,无临床意义,不良事件轻微且组间无差异。

核心结论

  • 在2型糖尿病风险成人中,限时进食4个月对HbA1c的改善非劣效于个体化营养指导,但12个月时非劣效性无法确定,两组绝对变化均无临床意义。

研究设计与样本

  • 两组平行、多中心随机非劣效临床试验,在澳大利亚两家临床研究机构开展,纳入超重或肥胖且澳大利亚2型糖尿病风险评估工具评分≥15的成人。
  • 两组在0至3个月间各接受5次针对分组定制的远程健康咨询(共3小时),主要结局为4个月时HbA1c变化的组间差异,非劣效界值设为1.1 mmol/mol(0.10%)。

主要发现

  • 4个月时限时进食对HbA1c非劣效但非优效于个体化营养指导(均值[95%CI]:-0.22[-0.72,0.30] mmol/mol;-0.02[-0.07,0.03]%;p=0.40)。
  • 12个月时组间差异上界超过非劣效界值0.10%,非劣效性无法确定(均值[95%CI]:0.47[-0.19,1.23] mmol/mol;0.05[-0.02,0.11]%;p=0.14)。
  • 两组在两个时间点的HbA1c绝对变化均较小且无临床意义,不良事件轻微且组间无差异。

关键数值与推荐

  • 非劣效界值设为1.1 mmol/mol(0.10%)。
  • 纳入标准为超重或肥胖且澳大利亚2型糖尿病风险评估工具评分≥15。
  • 限时进食方案为9小时自选进食窗口,末次进食不晚于19:00。
  • 两组均接受5次远程健康咨询,共3小时,在0至3个月间完成。

临床怎么用

  • 当营养师支持可及性有限或个体偏好该方式时,限时进食可作为2型糖尿病风险成人的短期务实替代选择。
  • 需告知患者限时进食的长期血糖获益尚未确证,12个月时非劣效性无法确定。

局限性

  • 12个月时限时进食的非劣效性无法确定,长期效果证据不足。
  • 两组HbA1c绝对变化均较小且无临床意义,研究结果的外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Time-restricted eating (TRE) consolidates daily energy intake to a consistent 6-10 h window. The aim was to assess whether TRE is non-inferior to individualised dietetic guidance (IDG) in changing HbA1c at 4 months in adults at risk of type 2 diabetes. METHODS: In a two-arm, parallel-group, multi-centre randomised, non-inferiority clinical trial at two Australian clinical research institutes, adults at risk of type 2 diabetes (i.e. with overweight or obesity and a score of ≥15 on the Australian type 2 diabetes risk assessment tool) were recruited. Participants were randomly assigned using an electronic system (1:1) to TRE (9 h, self-selected eating window, last eating occasion by 19:00 hours) or IDG. Staff conducting assessments and analyses were blinded to allocation; participants and dietitians were unblinded. Both groups received five personalised telehealth consultations between 0 and 3 months (3 h total), specific to their allocated group. The primary outcome was the between-group difference for change in HbA1c at 4 months assessed via covariate linear regression using multiple imputation with a non-inferiority margin set at 1.1 mmol/mol (0.10%). Secondary outcomes were change in HbA1c at 12 months and changes in fasting glucose, insulin, HOMA-IR and nocturnal glucose AUC. Exploratory outcomes included changes in cardiometabolic outcomes and body mass and composition. Adverse events were tracked for 12 months. RESULTS: One hundred and twenty four participants were randomised to TRE and 123 to IDG (mean ± SD HbA1c: 40 ± 3 mmol/mol [5.8 ± 0.3%]). At 4 months, TRE was non-inferior but not superior to IDG for HbA1c (mean [95% CI]: -0.22 [-0.72, 0.30] mmol/mol; -0.02 [-0.07, 0.03]%; p=0.40). At 12 months, the upper bound of the difference between groups was larger than the non-inferiority margin (0.10%) meaning that non-inferiority could no longer be concluded (mean [95% CI]: 0.47 [-0.19, 1.23] mmol/mol; 0.05 [-0.02, 0.11]%; p=0.14). However, the absolute changes in HbA1c were small and not clinically meaningful in either group at either time point. Adverse events were minor and not different between interventions. CONCLUSIONS/INTERPRETATION: TRE may offer a pragmatic and practical short-term alternative when access to dietetic support is limited, or if the approach is preferred by an individual. TRIAL REGISTRATION: ClinicalTrials.gov; NCT04762251 FUNDING: This research was funded by the Australian Government Medical Research Future Fund (MRFF 1200555).

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Parr EB, Charrouf R, Hutchison AT, et al. Time-restricted eating versus dietetic guidance on glycaemic outcomes in adults at risk of type 2 diabetes: a non-inferiority randomised clinical trial. Diabetologia. 2026. PMID: 42251202. doi:10.1007/s00125-026-06762-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。